Benefits
Bone health (context-dependent effect)
Pooled analyses show calcium plus vitamin D reduces total fractures by approximately 15% and hip fractures by approximately 30% in mixed populations. However, more recent analyses in community-dwelling older adults found no significant fracture reduction. Evidence is strongest for institutionalized older adults and those with low vitamin D status; modest for community-dwellers with adequate baseline intake. Routine supplementation in healthy ambulatory older adults isn't validated.
Cardiovascular concerns — supplements vs dietary
Multiple analyses since 2010 have reported that supplemental calcium may modestly increase cardiovascular events — relative risk roughly 1.15 for cardiovascular disease and 1.16 for coronary heart disease across 13 randomized trials. Industry-funded counter-analyses have challenged these findings. Honest framing: the signal is real and concerning but contested. Importantly, dietary calcium does not carry this signal — the concern applies specifically to supplemental boluses.
Pregnancy supplementation for preeclampsia prevention
The WHO recommends calcium supplementation (1.5-2 g/day) for women in low-calcium-intake populations to reduce preeclampsia risk. Recent noninferiority trials in India and Tanzania (over 11,000 women combined) showed that lower-dose 500 mg/day was noninferior to higher doses for preeclampsia prevention. This is the strongest pregnancy nutrition evidence base and is widely incorporated into prenatal protocols globally.
Muscle function and neuromuscular signaling
Calcium plays a central role in excitation-contraction coupling at the neuromuscular junction — sarcoplasmic reticulum calcium release directly drives muscle contraction. Adequate serum calcium is essential for normal muscle function. Hypocalcemia causes tetany, cramps, and numbness. Most people maintain serum calcium tightly through bone storage even with inadequate dietary intake — supplementation rarely fixes muscle symptoms in otherwise healthy adults.
Blood pressure (modest effect)
Calcium supplementation reduces systolic blood pressure by roughly 1-2 mmHg in adults. Effect is strongest in those with low baseline calcium intake (under 800 mg/day). Smaller effect than potassium or magnesium supplementation. The DASH diet (high in dairy and other minerals) shows larger BP effects than calcium alone — whole-food approaches outperform isolated calcium supplementation for blood pressure.
Dental health and tooth structure
Calcium is the primary mineral component of tooth enamel and dentin. Adequate calcium intake during tooth development (childhood and adolescence) supports permanent tooth strength. In adults, dietary calcium plus fluoride and adequate vitamin D supports enamel remineralization. Limited evidence that adult calcium supplementation prevents tooth decay beyond meeting RDA.
Electrolyte support during exercise
Calcium is among the electrolytes lost in sweat (roughly 30-60 mg/L), though in smaller quantities than sodium or potassium. Athletes producing 2-3 L sweat per session lose 60-180 mg calcium per workout. Modern sports hydration formulas include 50-100 mg calcium per serving alongside sodium, potassium, and magnesium. Most relevant for endurance athletes and those training in heat.
Food vs supplement (important distinction)
Most cardiovascular concerns apply to supplemental calcium (especially without vitamin D), not dietary calcium from dairy, leafy greens, or fortified foods. Dietary calcium is absorbed gradually with meals; supplemental boluses cause sharp serum spikes that may drive vascular calcification over time. Best practice: meet calcium needs through diet first, supplement only if dietary intake falls below 800 mg/day.
Mechanism of action
Bone mineralization and remodeling
About 99% of body calcium is stored as hydroxyapatite in bone matrix. Bone is metabolically active — continuously remodeled by osteoclasts (resorption) and osteoblasts (formation). Adequate calcium supports the formation phase; vitamin D enables intestinal absorption. Without adequate calcium and D, parathyroid hormone mobilizes calcium from bone to maintain serum levels.
Excitation-contraction coupling in muscle
Action potentials trigger sarcoplasmic reticulum calcium release. Released Ca²⁺ binds troponin, exposing actin-binding sites for myosin to drive contraction. Calcium reuptake by SERCA pumps allows relaxation. This calcium cycling occurs millions of times per day in skeletal and cardiac muscle.
Nerve transmission
Calcium influx through voltage-gated calcium channels at the presynaptic terminal triggers neurotransmitter vesicle fusion. Without adequate calcium, synaptic transmission fails. Hypocalcemia causes hyperexcitability through reduced threshold for sodium channel opening — manifests as tetany and cramps.
Blood clotting cascade
Calcium is Coagulation Factor IV. It serves as a cofactor for activation of multiple clotting factors (II, VII, IX, X) and is essential for fibrin formation. EDTA chelation of calcium prevents clotting in lab tubes — illustrating calcium's foundational role.
Cardiac action potential
Calcium current is responsible for the plateau phase of cardiac action potentials. Calcium-induced calcium release from cardiac sarcoplasmic reticulum drives contraction. Hypocalcemia prolongs QT interval; hypercalcemia shortens it. Both extremes increase arrhythmia risk.
Clinical trials
Reanalysis of the Women's Health Initiative limited-access dataset combined with pooled analysis of 13 clinical trials. Triggered the modern concern about supplemental calcium and cardiovascular events. Published in BMJ (342:d2040).
Pooled across 13 clinical trials evaluating calcium with or without vitamin D vs placebo. Mostly postmenopausal women.
Calcium with or without vitamin D was associated with approximately 30% increased myocardial infarction risk (RR 1.27, 95% CI 1.01-1.59). Effect was most pronounced in trials of calcium alone (no vitamin D). This finding fundamentally changed the risk-benefit calculation for routine calcium supplementation and led to more cautious clinical guidelines for supplemental calcium use.
Pooled analysis of double-blind placebo-controlled clinical trials evaluating calcium supplementation for cardiovascular disease risk. Published in Nutrients. Modern methodology updating the earlier controversial analyses.
28,935 adults across 13 double-blind placebo-controlled clinical trials (14,692 intervention vs 14,243 control).
Calcium supplementation increased CVD risk (RR 1.15, 95% CI 1.06-1.25) and CHD risk (RR 1.16) vs placebo. The effect size is modest in absolute terms but statistically robust across multiple analyses. Confirms the consistent direction of the cardiovascular signal across modern reanalyses, though industry-funded analyses have continued to challenge the findings.
Evidence review and pooled analysis specifically in community-dwelling older adults (excluding institutionalized populations where benefits are clearer). Published in JAMA. Distinguished between trial populations more carefully than earlier pooled analyses.
51,145 community-dwelling older adults across 33 clinical trials.
Calcium, vitamin D, or the combination was not associated with reduced fracture incidence in community-dwelling participants — contradicting long-held assumptions. Effect remains positive in institutionalized older adults and those with documented deficiency. Major implication: routine supplementation in healthy ambulatory older adults isn't validated for fracture prevention.
Foundational randomized double-blind placebo-controlled trial of calcium plus vitamin D in postmenopausal women. Long 7-year intervention captures durable bone outcomes. Among the largest nutrition intervention trials ever conducted in women.
36,282 postmenopausal women randomized to 1,000 mg calcium + 400 IU vitamin D vs placebo. 7-year intervention.
Calcium + vitamin D supplementation produced modest improvement in hip bone density but NO significant reduction in clinical fractures vs placebo. The vitamin D dose was likely too low by modern standards (400 IU). Reanalysis of this trial's limited-access dataset later contributed to the cardiovascular concern signal that emerged in subsequent pooled analyses.
Two large randomized noninferiority trials conducted in India and Tanzania to evaluate whether lower-dose calcium (500 mg/day) is noninferior to higher doses for preeclampsia prevention in low-calcium-intake populations. Published in 2024.
Over 11,000 pregnant women combined across the two trials, all from low-calcium-intake populations.
Lower-dose 500 mg/day calcium was noninferior to higher doses for preeclampsia prevention. This simplifies global guidance — particularly for low-resource settings where higher-dose calcium presents cost and compliance challenges. Validates calcium supplementation specifically in the at-risk pregnancy population while supporting lower doses than previously recommended.